Hearts from hepatitis c donors offer new hope for transplant patients
NCT ID NCT03222531
First seen Nov 01, 2025 · Last updated Apr 26, 2026 · Updated 19 times
Summary
This study tests whether hearts from donors with hepatitis C can be safely transplanted into people who do not have the virus. Twenty adults with end-stage heart failure on the transplant waiting list will receive a heart from a hepatitis C positive donor. They will be treated with antiviral medication to prevent or cure any infection. The goal is to expand the pool of available donor hearts and reduce wait times.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEART TRANSPLANT are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
UPMC
Pittsburgh, Pennsylvania, 15213, United States
Conditions
Explore the condition pages connected to this study.